Cat. No. 4812
Biological ActivityPotent and selective KV1.3 channel blocker (IC50 values are 0.0019 and 0.65 nM for KV1.3 and KV1.1, respectively). Inhibits CD4+ CCR7- T cell activation. Ameliorates rat experimental autoimmune encephalomyelitis, in a model for multiple sclerosis.
(Modifications: Disulfide bridge: 7 - 27, 13 - 32, 17 - 34)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Li et al (2012) Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model. J.Biol.Chem. 287 29479. PMID: 22761436.
Han et al (2008) Structural basis of a potent peptide inhibitor designed for KV1.3 channel, a therapeutic target of autoimmune disease. J.Biol.Chem. 283 19058. PMID: 18480054.
If you know of a relevant reference for ADWX 1 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ADWX 1 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: ADWX 1, supplier, ADWX1, KV1.3, potassium, channels, blockers, CD4+, CCR7-, T-cell, autoimmune, encephalomyelitis, multiple, sclerosis., Tocris Bioscience, Voltage-gated Potassium (KV) Channel Blocker products